In order to investigate the mechanism of action of bile acids in AD, Wu et al. applied Aβ1–42 to establish an AD model, and gave the G protein-coupled bile acid receptor 1 (GPBAR1) agonist INT-777 as a treatment [95]. The gene discussed is GPBAR1; the disease is Alzheimer disease.